nodes	percent_of_prediction	percent_of_DWPC	metapath
Nebivolol—CYP2D6—Temsirolimus—kidney cancer	0.193	0.372	CbGbCtD
Nebivolol—CYP2D6—Pazopanib—kidney cancer	0.102	0.195	CbGbCtD
Nebivolol—CYP2D6—Erlotinib—kidney cancer	0.0725	0.139	CbGbCtD
Nebivolol—CYP2D6—Sorafenib—kidney cancer	0.0589	0.113	CbGbCtD
Nebivolol—CYP2D6—Vinblastine—kidney cancer	0.0582	0.112	CbGbCtD
Nebivolol—CYP2D6—Doxorubicin—kidney cancer	0.0357	0.0687	CbGbCtD
Nebivolol—Cardiac disorder—Gemcitabine—kidney cancer	0.00129	0.00268	CcSEcCtD
Nebivolol—Insomnia—Erlotinib—kidney cancer	0.00128	0.00268	CcSEcCtD
Nebivolol—Chest pain—Sunitinib—kidney cancer	0.00128	0.00267	CcSEcCtD
Nebivolol—Mental disorder—Vincristine—kidney cancer	0.00128	0.00267	CcSEcCtD
Nebivolol—Acute coronary syndrome—Paclitaxel—kidney cancer	0.00128	0.00266	CcSEcCtD
Nebivolol—Diarrhoea—Pazopanib—kidney cancer	0.00128	0.00266	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Sunitinib—kidney cancer	0.00127	0.00265	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Everolimus—kidney cancer	0.00127	0.00265	CcSEcCtD
Nebivolol—Myocardial infarction—Paclitaxel—kidney cancer	0.00127	0.00264	CcSEcCtD
Nebivolol—Fatigue—Everolimus—kidney cancer	0.00127	0.00264	CcSEcCtD
Nebivolol—Dyspnoea—Erlotinib—kidney cancer	0.00127	0.00264	CcSEcCtD
Nebivolol—Atrioventricular block—Doxorubicin—kidney cancer	0.00126	0.00263	CcSEcCtD
Nebivolol—Vomiting—Temsirolimus—kidney cancer	0.00126	0.00262	CcSEcCtD
Nebivolol—Shock—Sorafenib—kidney cancer	0.00126	0.00262	CcSEcCtD
Nebivolol—Nervous system disorder—Sorafenib—kidney cancer	0.00125	0.00261	CcSEcCtD
Nebivolol—Thrombocytopenia—Sorafenib—kidney cancer	0.00125	0.00261	CcSEcCtD
Nebivolol—Rash—Temsirolimus—kidney cancer	0.00125	0.0026	CcSEcCtD
Nebivolol—Dermatitis—Temsirolimus—kidney cancer	0.00125	0.0026	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Capecitabine—kidney cancer	0.00124	0.00259	CcSEcCtD
Nebivolol—Skin disorder—Sorafenib—kidney cancer	0.00124	0.00259	CcSEcCtD
Nebivolol—Headache—Temsirolimus—kidney cancer	0.00124	0.00258	CcSEcCtD
Nebivolol—Dizziness—Pazopanib—kidney cancer	0.00123	0.00257	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Erlotinib—kidney cancer	0.00123	0.00255	CcSEcCtD
Nebivolol—Fatigue—Erlotinib—kidney cancer	0.00122	0.00255	CcSEcCtD
Nebivolol—Shock—Sunitinib—kidney cancer	0.00121	0.00252	CcSEcCtD
Nebivolol—Gastrointestinal pain—Vinblastine—kidney cancer	0.00121	0.00252	CcSEcCtD
Nebivolol—Nervous system disorder—Sunitinib—kidney cancer	0.00121	0.00251	CcSEcCtD
Nebivolol—Thrombocytopenia—Sunitinib—kidney cancer	0.0012	0.00251	CcSEcCtD
Nebivolol—Gastrointestinal pain—Everolimus—kidney cancer	0.0012	0.00251	CcSEcCtD
Nebivolol—Skin disorder—Sunitinib—kidney cancer	0.00119	0.00249	CcSEcCtD
Nebivolol—Vomiting—Pazopanib—kidney cancer	0.00118	0.00247	CcSEcCtD
Nebivolol—Bradycardia—Paclitaxel—kidney cancer	0.00118	0.00247	CcSEcCtD
Nebivolol—Rash—Pazopanib—kidney cancer	0.00118	0.00245	CcSEcCtD
Nebivolol—Nausea—Temsirolimus—kidney cancer	0.00117	0.00245	CcSEcCtD
Nebivolol—Dermatitis—Pazopanib—kidney cancer	0.00117	0.00245	CcSEcCtD
Nebivolol—Bronchospasm—Capecitabine—kidney cancer	0.00117	0.00244	CcSEcCtD
Nebivolol—Abdominal pain—Vinblastine—kidney cancer	0.00117	0.00243	CcSEcCtD
Nebivolol—Headache—Pazopanib—kidney cancer	0.00117	0.00243	CcSEcCtD
Nebivolol—Abdominal pain—Everolimus—kidney cancer	0.00116	0.00242	CcSEcCtD
Nebivolol—Gastrointestinal pain—Erlotinib—kidney cancer	0.00116	0.00242	CcSEcCtD
Nebivolol—Oedema peripheral—Paclitaxel—kidney cancer	0.00114	0.00239	CcSEcCtD
Nebivolol—Vertigo—Vincristine—kidney cancer	0.00114	0.00238	CcSEcCtD
Nebivolol—Thrombocytopenia—Dactinomycin—kidney cancer	0.00114	0.00237	CcSEcCtD
Nebivolol—Dyspnoea—Sorafenib—kidney cancer	0.00114	0.00237	CcSEcCtD
Nebivolol—Abdominal pain—Erlotinib—kidney cancer	0.00112	0.00234	CcSEcCtD
Nebivolol—Insomnia—Sunitinib—kidney cancer	0.00111	0.00232	CcSEcCtD
Nebivolol—Nausea—Pazopanib—kidney cancer	0.00111	0.00231	CcSEcCtD
Nebivolol—Paraesthesia—Sunitinib—kidney cancer	0.0011	0.0023	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Sorafenib—kidney cancer	0.0011	0.0023	CcSEcCtD
Nebivolol—Fatigue—Sorafenib—kidney cancer	0.0011	0.00229	CcSEcCtD
Nebivolol—Dyspnoea—Sunitinib—kidney cancer	0.0011	0.00228	CcSEcCtD
Nebivolol—Hypersensitivity—Vinblastine—kidney cancer	0.00109	0.00227	CcSEcCtD
Nebivolol—Hypersensitivity—Everolimus—kidney cancer	0.00108	0.00226	CcSEcCtD
Nebivolol—Cardiac disorder—Paclitaxel—kidney cancer	0.00108	0.00225	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Sunitinib—kidney cancer	0.00106	0.00221	CcSEcCtD
Nebivolol—Asthenia—Vinblastine—kidney cancer	0.00106	0.00221	CcSEcCtD
Nebivolol—Fatigue—Sunitinib—kidney cancer	0.00106	0.00221	CcSEcCtD
Nebivolol—Asthenia—Everolimus—kidney cancer	0.00106	0.0022	CcSEcCtD
Nebivolol—Acute coronary syndrome—Capecitabine—kidney cancer	0.00105	0.00218	CcSEcCtD
Nebivolol—Gastrointestinal pain—Sorafenib—kidney cancer	0.00104	0.00218	CcSEcCtD
Nebivolol—Myocardial infarction—Capecitabine—kidney cancer	0.00104	0.00217	CcSEcCtD
Nebivolol—Pruritus—Everolimus—kidney cancer	0.00104	0.00217	CcSEcCtD
Nebivolol—Chest pain—Gemcitabine—kidney cancer	0.00103	0.00214	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.00102	0.00213	CcSEcCtD
Nebivolol—Nervous system disorder—Vincristine—kidney cancer	0.00102	0.00212	CcSEcCtD
Nebivolol—Asthenia—Erlotinib—kidney cancer	0.00102	0.00212	CcSEcCtD
Nebivolol—Mental disorder—Paclitaxel—kidney cancer	0.00102	0.00212	CcSEcCtD
Nebivolol—Thrombocytopenia—Vincristine—kidney cancer	0.00102	0.00212	CcSEcCtD
Nebivolol—Urticaria—Sorafenib—kidney cancer	0.00101	0.00211	CcSEcCtD
Nebivolol—Malnutrition—Paclitaxel—kidney cancer	0.00101	0.00211	CcSEcCtD
Nebivolol—Diarrhoea—Vinblastine—kidney cancer	0.00101	0.00211	CcSEcCtD
Nebivolol—Abdominal pain—Sorafenib—kidney cancer	0.00101	0.0021	CcSEcCtD
Nebivolol—Diarrhoea—Everolimus—kidney cancer	0.00101	0.0021	CcSEcCtD
Nebivolol—Gastrointestinal pain—Sunitinib—kidney cancer	0.001	0.00209	CcSEcCtD
Nebivolol—Pruritus—Erlotinib—kidney cancer	0.001	0.00209	CcSEcCtD
Nebivolol—Fatigue—Dactinomycin—kidney cancer	0.001	0.00209	CcSEcCtD
Nebivolol—Dizziness—Vinblastine—kidney cancer	0.000977	0.00204	CcSEcCtD
Nebivolol—Dizziness—Everolimus—kidney cancer	0.000973	0.00203	CcSEcCtD
Nebivolol—Abdominal pain—Sunitinib—kidney cancer	0.000972	0.00202	CcSEcCtD
Nebivolol—Diarrhoea—Erlotinib—kidney cancer	0.000971	0.00202	CcSEcCtD
Nebivolol—Bradycardia—Capecitabine—kidney cancer	0.000971	0.00202	CcSEcCtD
Nebivolol—Nervous system disorder—Gemcitabine—kidney cancer	0.000967	0.00202	CcSEcCtD
Nebivolol—Thrombocytopenia—Gemcitabine—kidney cancer	0.000966	0.00201	CcSEcCtD
Nebivolol—Renal failure acute—Doxorubicin—kidney cancer	0.000963	0.00201	CcSEcCtD
Nebivolol—Skin disorder—Gemcitabine—kidney cancer	0.000958	0.002	CcSEcCtD
Nebivolol—Gastrointestinal pain—Dactinomycin—kidney cancer	0.000951	0.00198	CcSEcCtD
Nebivolol—Hypersensitivity—Sorafenib—kidney cancer	0.000941	0.00196	CcSEcCtD
Nebivolol—Insomnia—Vincristine—kidney cancer	0.00094	0.00196	CcSEcCtD
Nebivolol—Oedema peripheral—Capecitabine—kidney cancer	0.00094	0.00196	CcSEcCtD
Nebivolol—Vomiting—Vinblastine—kidney cancer	0.000939	0.00196	CcSEcCtD
Nebivolol—Dizziness—Erlotinib—kidney cancer	0.000939	0.00196	CcSEcCtD
Nebivolol—Vomiting—Everolimus—kidney cancer	0.000936	0.00195	CcSEcCtD
Nebivolol—Paraesthesia—Vincristine—kidney cancer	0.000933	0.00195	CcSEcCtD
Nebivolol—Rash—Everolimus—kidney cancer	0.000928	0.00193	CcSEcCtD
Nebivolol—Dermatitis—Everolimus—kidney cancer	0.000927	0.00193	CcSEcCtD
Nebivolol—Headache—Vinblastine—kidney cancer	0.000925	0.00193	CcSEcCtD
Nebivolol—Angioedema—Paclitaxel—kidney cancer	0.000924	0.00193	CcSEcCtD
Nebivolol—Headache—Everolimus—kidney cancer	0.000922	0.00192	CcSEcCtD
Nebivolol—Abdominal pain—Dactinomycin—kidney cancer	0.00092	0.00192	CcSEcCtD
Nebivolol—Asthenia—Sorafenib—kidney cancer	0.000916	0.00191	CcSEcCtD
Nebivolol—Vertigo—Paclitaxel—kidney cancer	0.000909	0.00189	CcSEcCtD
Nebivolol—Syncope—Paclitaxel—kidney cancer	0.000907	0.00189	CcSEcCtD
Nebivolol—Hypersensitivity—Sunitinib—kidney cancer	0.000905	0.00189	CcSEcCtD
Nebivolol—Pruritus—Sorafenib—kidney cancer	0.000904	0.00188	CcSEcCtD
Nebivolol—Vomiting—Erlotinib—kidney cancer	0.000903	0.00188	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Vincristine—kidney cancer	0.000897	0.00187	CcSEcCtD
Nebivolol—Fatigue—Vincristine—kidney cancer	0.000896	0.00187	CcSEcCtD
Nebivolol—Rash—Erlotinib—kidney cancer	0.000895	0.00187	CcSEcCtD
Nebivolol—Dermatitis—Erlotinib—kidney cancer	0.000894	0.00186	CcSEcCtD
Nebivolol—Insomnia—Gemcitabine—kidney cancer	0.000892	0.00186	CcSEcCtD
Nebivolol—Headache—Erlotinib—kidney cancer	0.000889	0.00185	CcSEcCtD
Nebivolol—Loss of consciousness—Paclitaxel—kidney cancer	0.000889	0.00185	CcSEcCtD
Nebivolol—Paraesthesia—Gemcitabine—kidney cancer	0.000886	0.00185	CcSEcCtD
Nebivolol—Cardiac disorder—Capecitabine—kidney cancer	0.000885	0.00184	CcSEcCtD
Nebivolol—Asthenia—Sunitinib—kidney cancer	0.000882	0.00184	CcSEcCtD
Nebivolol—Dyspnoea—Gemcitabine—kidney cancer	0.000879	0.00183	CcSEcCtD
Nebivolol—Nausea—Vinblastine—kidney cancer	0.000877	0.00183	CcSEcCtD
Nebivolol—Somnolence—Gemcitabine—kidney cancer	0.000877	0.00183	CcSEcCtD
Nebivolol—Nausea—Everolimus—kidney cancer	0.000874	0.00182	CcSEcCtD
Nebivolol—Diarrhoea—Sorafenib—kidney cancer	0.000874	0.00182	CcSEcCtD
Nebivolol—Pruritus—Sunitinib—kidney cancer	0.00087	0.00181	CcSEcCtD
Nebivolol—Chest pain—Paclitaxel—kidney cancer	0.000861	0.00179	CcSEcCtD
Nebivolol—Hypersensitivity—Dactinomycin—kidney cancer	0.000857	0.00179	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000855	0.00178	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000851	0.00177	CcSEcCtD
Nebivolol—Fatigue—Gemcitabine—kidney cancer	0.00085	0.00177	CcSEcCtD
Nebivolol—Gastrointestinal pain—Vincristine—kidney cancer	0.00085	0.00177	CcSEcCtD
Nebivolol—Dizziness—Sorafenib—kidney cancer	0.000845	0.00176	CcSEcCtD
Nebivolol—Nausea—Erlotinib—kidney cancer	0.000843	0.00176	CcSEcCtD
Nebivolol—Diarrhoea—Sunitinib—kidney cancer	0.000841	0.00175	CcSEcCtD
Nebivolol—Mental disorder—Capecitabine—kidney cancer	0.000836	0.00174	CcSEcCtD
Nebivolol—Asthenia—Dactinomycin—kidney cancer	0.000835	0.00174	CcSEcCtD
Nebivolol—Malnutrition—Capecitabine—kidney cancer	0.00083	0.00173	CcSEcCtD
Nebivolol—Abdominal pain—Vincristine—kidney cancer	0.000822	0.00171	CcSEcCtD
Nebivolol—Dizziness—Sunitinib—kidney cancer	0.000813	0.00169	CcSEcCtD
Nebivolol—Shock—Paclitaxel—kidney cancer	0.000812	0.00169	CcSEcCtD
Nebivolol—Vomiting—Sorafenib—kidney cancer	0.000812	0.00169	CcSEcCtD
Nebivolol—Nervous system disorder—Paclitaxel—kidney cancer	0.00081	0.00169	CcSEcCtD
Nebivolol—Thrombocytopenia—Paclitaxel—kidney cancer	0.000808	0.00168	CcSEcCtD
Nebivolol—Rash—Sorafenib—kidney cancer	0.000805	0.00168	CcSEcCtD
Nebivolol—Dermatitis—Sorafenib—kidney cancer	0.000805	0.00168	CcSEcCtD
Nebivolol—Skin disorder—Paclitaxel—kidney cancer	0.000802	0.00167	CcSEcCtD
Nebivolol—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	0.0008	0.00167	CcSEcCtD
Nebivolol—Headache—Sorafenib—kidney cancer	0.0008	0.00167	CcSEcCtD
Nebivolol—Diarrhoea—Dactinomycin—kidney cancer	0.000796	0.00166	CcSEcCtD
Nebivolol—Vomiting—Sunitinib—kidney cancer	0.000781	0.00163	CcSEcCtD
Nebivolol—Rash—Sunitinib—kidney cancer	0.000775	0.00161	CcSEcCtD
Nebivolol—Dermatitis—Sunitinib—kidney cancer	0.000774	0.00161	CcSEcCtD
Nebivolol—Headache—Sunitinib—kidney cancer	0.00077	0.0016	CcSEcCtD
Nebivolol—Hypersensitivity—Vincristine—kidney cancer	0.000766	0.0016	CcSEcCtD
Nebivolol—Nausea—Sorafenib—kidney cancer	0.000759	0.00158	CcSEcCtD
Nebivolol—Insomnia—Paclitaxel—kidney cancer	0.000747	0.00156	CcSEcCtD
Nebivolol—Vertigo—Capecitabine—kidney cancer	0.000746	0.00155	CcSEcCtD
Nebivolol—Asthenia—Vincristine—kidney cancer	0.000746	0.00155	CcSEcCtD
Nebivolol—Syncope—Capecitabine—kidney cancer	0.000745	0.00155	CcSEcCtD
Nebivolol—Paraesthesia—Paclitaxel—kidney cancer	0.000741	0.00154	CcSEcCtD
Nebivolol—Vomiting—Dactinomycin—kidney cancer	0.00074	0.00154	CcSEcCtD
Nebivolol—Dyspnoea—Paclitaxel—kidney cancer	0.000736	0.00153	CcSEcCtD
Nebivolol—Somnolence—Paclitaxel—kidney cancer	0.000734	0.00153	CcSEcCtD
Nebivolol—Rash—Dactinomycin—kidney cancer	0.000734	0.00153	CcSEcCtD
Nebivolol—Nausea—Sunitinib—kidney cancer	0.00073	0.00152	CcSEcCtD
Nebivolol—Loss of consciousness—Capecitabine—kidney cancer	0.00073	0.00152	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Paclitaxel—kidney cancer	0.000713	0.00149	CcSEcCtD
Nebivolol—Fatigue—Paclitaxel—kidney cancer	0.000712	0.00148	CcSEcCtD
Nebivolol—Diarrhoea—Vincristine—kidney cancer	0.000711	0.00148	CcSEcCtD
Nebivolol—Asthenia—Gemcitabine—kidney cancer	0.000708	0.00147	CcSEcCtD
Nebivolol—Chest pain—Capecitabine—kidney cancer	0.000707	0.00147	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	0.000702	0.00146	CcSEcCtD
Nebivolol—Pruritus—Gemcitabine—kidney cancer	0.000698	0.00145	CcSEcCtD
Nebivolol—Nausea—Dactinomycin—kidney cancer	0.000691	0.00144	CcSEcCtD
Nebivolol—Dizziness—Vincristine—kidney cancer	0.000687	0.00143	CcSEcCtD
Nebivolol—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000675	0.00141	CcSEcCtD
Nebivolol—Diarrhoea—Gemcitabine—kidney cancer	0.000675	0.00141	CcSEcCtD
Nebivolol—Shock—Capecitabine—kidney cancer	0.000667	0.00139	CcSEcCtD
Nebivolol—Nervous system disorder—Capecitabine—kidney cancer	0.000664	0.00138	CcSEcCtD
Nebivolol—Thrombocytopenia—Capecitabine—kidney cancer	0.000663	0.00138	CcSEcCtD
Nebivolol—Vomiting—Vincristine—kidney cancer	0.000661	0.00138	CcSEcCtD
Nebivolol—Skin disorder—Capecitabine—kidney cancer	0.000658	0.00137	CcSEcCtD
Nebivolol—Urticaria—Paclitaxel—kidney cancer	0.000656	0.00137	CcSEcCtD
Nebivolol—Rash—Vincristine—kidney cancer	0.000655	0.00137	CcSEcCtD
Nebivolol—Dermatitis—Vincristine—kidney cancer	0.000655	0.00136	CcSEcCtD
Nebivolol—Abdominal pain—Paclitaxel—kidney cancer	0.000653	0.00136	CcSEcCtD
Nebivolol—Headache—Vincristine—kidney cancer	0.000651	0.00136	CcSEcCtD
Nebivolol—Vomiting—Gemcitabine—kidney cancer	0.000627	0.00131	CcSEcCtD
Nebivolol—Bradycardia—Doxorubicin—kidney cancer	0.000626	0.0013	CcSEcCtD
Nebivolol—Rash—Gemcitabine—kidney cancer	0.000622	0.0013	CcSEcCtD
Nebivolol—Dermatitis—Gemcitabine—kidney cancer	0.000621	0.00129	CcSEcCtD
Nebivolol—Headache—Gemcitabine—kidney cancer	0.000618	0.00129	CcSEcCtD
Nebivolol—Nausea—Vincristine—kidney cancer	0.000617	0.00129	CcSEcCtD
Nebivolol—Insomnia—Capecitabine—kidney cancer	0.000613	0.00128	CcSEcCtD
Nebivolol—Paraesthesia—Capecitabine—kidney cancer	0.000608	0.00127	CcSEcCtD
Nebivolol—Hypersensitivity—Paclitaxel—kidney cancer	0.000608	0.00127	CcSEcCtD
Nebivolol—Oedema peripheral—Doxorubicin—kidney cancer	0.000606	0.00126	CcSEcCtD
Nebivolol—Dyspnoea—Capecitabine—kidney cancer	0.000604	0.00126	CcSEcCtD
Nebivolol—Asthenia—Paclitaxel—kidney cancer	0.000592	0.00123	CcSEcCtD
Nebivolol—Nausea—Gemcitabine—kidney cancer	0.000586	0.00122	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Capecitabine—kidney cancer	0.000585	0.00122	CcSEcCtD
Nebivolol—Fatigue—Capecitabine—kidney cancer	0.000584	0.00122	CcSEcCtD
Nebivolol—Pruritus—Paclitaxel—kidney cancer	0.000584	0.00122	CcSEcCtD
Nebivolol—Cardiac disorder—Doxorubicin—kidney cancer	0.000571	0.00119	CcSEcCtD
Nebivolol—Diarrhoea—Paclitaxel—kidney cancer	0.000565	0.00118	CcSEcCtD
Nebivolol—Gastrointestinal pain—Capecitabine—kidney cancer	0.000554	0.00115	CcSEcCtD
Nebivolol—Dizziness—Paclitaxel—kidney cancer	0.000546	0.00114	CcSEcCtD
Nebivolol—Mental disorder—Doxorubicin—kidney cancer	0.000539	0.00112	CcSEcCtD
Nebivolol—Urticaria—Capecitabine—kidney cancer	0.000538	0.00112	CcSEcCtD
Nebivolol—Abdominal pain—Capecitabine—kidney cancer	0.000536	0.00112	CcSEcCtD
Nebivolol—Malnutrition—Doxorubicin—kidney cancer	0.000535	0.00112	CcSEcCtD
Nebivolol—Vomiting—Paclitaxel—kidney cancer	0.000525	0.00109	CcSEcCtD
Nebivolol—Rash—Paclitaxel—kidney cancer	0.000521	0.00108	CcSEcCtD
Nebivolol—Dermatitis—Paclitaxel—kidney cancer	0.00052	0.00108	CcSEcCtD
Nebivolol—Headache—Paclitaxel—kidney cancer	0.000517	0.00108	CcSEcCtD
Nebivolol—Hypersensitivity—Capecitabine—kidney cancer	0.000499	0.00104	CcSEcCtD
Nebivolol—Nausea—Paclitaxel—kidney cancer	0.00049	0.00102	CcSEcCtD
Nebivolol—Asthenia—Capecitabine—kidney cancer	0.000486	0.00101	CcSEcCtD
Nebivolol—Vertigo—Doxorubicin—kidney cancer	0.000481	0.001	CcSEcCtD
Nebivolol—Syncope—Doxorubicin—kidney cancer	0.00048	0.001	CcSEcCtD
Nebivolol—Pruritus—Capecitabine—kidney cancer	0.000479	0.000999	CcSEcCtD
Nebivolol—Loss of consciousness—Doxorubicin—kidney cancer	0.00047	0.00098	CcSEcCtD
Nebivolol—Diarrhoea—Capecitabine—kidney cancer	0.000464	0.000966	CcSEcCtD
Nebivolol—Chest pain—Doxorubicin—kidney cancer	0.000456	0.000949	CcSEcCtD
Nebivolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	0.000452	0.000943	CcSEcCtD
Nebivolol—Dizziness—Capecitabine—kidney cancer	0.000448	0.000934	CcSEcCtD
Nebivolol—Vomiting—Capecitabine—kidney cancer	0.000431	0.000898	CcSEcCtD
Nebivolol—Shock—Doxorubicin—kidney cancer	0.00043	0.000895	CcSEcCtD
Nebivolol—Nervous system disorder—Doxorubicin—kidney cancer	0.000428	0.000893	CcSEcCtD
Nebivolol—Thrombocytopenia—Doxorubicin—kidney cancer	0.000428	0.000891	CcSEcCtD
Nebivolol—Rash—Capecitabine—kidney cancer	0.000427	0.00089	CcSEcCtD
Nebivolol—Dermatitis—Capecitabine—kidney cancer	0.000427	0.000889	CcSEcCtD
Nebivolol—Headache—Capecitabine—kidney cancer	0.000424	0.000884	CcSEcCtD
Nebivolol—Skin disorder—Doxorubicin—kidney cancer	0.000424	0.000884	CcSEcCtD
Nebivolol—Nausea—Capecitabine—kidney cancer	0.000402	0.000839	CcSEcCtD
Nebivolol—Insomnia—Doxorubicin—kidney cancer	0.000395	0.000823	CcSEcCtD
Nebivolol—Paraesthesia—Doxorubicin—kidney cancer	0.000392	0.000817	CcSEcCtD
Nebivolol—Dyspnoea—Doxorubicin—kidney cancer	0.000389	0.000811	CcSEcCtD
Nebivolol—Somnolence—Doxorubicin—kidney cancer	0.000388	0.000809	CcSEcCtD
Nebivolol—Gastrointestinal disorder—Doxorubicin—kidney cancer	0.000377	0.000786	CcSEcCtD
Nebivolol—Fatigue—Doxorubicin—kidney cancer	0.000377	0.000785	CcSEcCtD
Nebivolol—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000357	0.000744	CcSEcCtD
Nebivolol—Urticaria—Doxorubicin—kidney cancer	0.000347	0.000723	CcSEcCtD
Nebivolol—Abdominal pain—Doxorubicin—kidney cancer	0.000345	0.000719	CcSEcCtD
Nebivolol—Hypersensitivity—Doxorubicin—kidney cancer	0.000322	0.000671	CcSEcCtD
Nebivolol—Asthenia—Doxorubicin—kidney cancer	0.000313	0.000653	CcSEcCtD
Nebivolol—Pruritus—Doxorubicin—kidney cancer	0.000309	0.000644	CcSEcCtD
Nebivolol—Diarrhoea—Doxorubicin—kidney cancer	0.000299	0.000623	CcSEcCtD
Nebivolol—Dizziness—Doxorubicin—kidney cancer	0.000289	0.000602	CcSEcCtD
Nebivolol—Vomiting—Doxorubicin—kidney cancer	0.000278	0.000579	CcSEcCtD
Nebivolol—Rash—Doxorubicin—kidney cancer	0.000275	0.000574	CcSEcCtD
Nebivolol—Dermatitis—Doxorubicin—kidney cancer	0.000275	0.000573	CcSEcCtD
Nebivolol—Headache—Doxorubicin—kidney cancer	0.000274	0.00057	CcSEcCtD
Nebivolol—Nausea—Doxorubicin—kidney cancer	0.000259	0.000541	CcSEcCtD
